DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimens
FDA Recall Z-0677-2025 · Posted 2024-12-12
Advertisement
Recalling FirmDiasorin Inc.
Recall StatusOpen, Classified
Product CodeNXO
Date Initiated2024-11-07
Product Quantity21905 units
Reason for Recall
Customer complaints were received alleging leaking devices and insufficient buffer volume. Diasorin's internal investigation determined that 0.14% of the LIAISON Q.S.E.T. Device Plus in the lots identified have loose clear caps, which may allow buffer to leak from the tube. A stool sample prepared with less than the correct amount of buffer may result an incorrectly high patient result.
Firm Action
DiaSorn issued an Urgent Field Safety Notice - Medical Device Recall notice to its consignees on 11/07/2024 via email. The notice explained the issue with the product, risk to health, and requested the following:
"Ac xons to be taken by the Customer/User
" No need to review past patient results.
" Devices should be inspected for loose clear caps prior to use. The user should confirm that the clear cap is tight by grasping the cap and twisting. If the cap is loose, the device should be discarded. Do not attempt to use the device as the loose clear cap may have allowed buffer to leak, causing insufficient buffer volume.
" Customers should forward this communication to required individuals within the organization or to any organization where the potentially affected devices have been distributed.
" Diasorin will replace any tubes found with loose clear caps. Contact Diasorin Product Support for replacement product."
For questions or concerns, contact:
Diasorin Product Support: 1-800-328-1482 Select Option 1 (U.S. and Canada); 1-651-351-5888 (Fax); [email protected]
Root Cause
Process control
Distribution Pattern
Worldwide
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement